Aerpio Therapeutics Inc. has named a new chief medical officer. The company has named Dr. Steve Pakola to the newly created role. Pakola will lead the advancement of company's development pipeline and report to president and CEO Joseph Gardner, effective immediately.

Pakola was most recently chief medical officer at Amakem. He was previously chief medical officer at ThromboGenics NV, where he was the lead inventor and developer of the company's main product. His other previous roles include senior-level clinical development positions at Boehringer Ingelheim Pharmaceuticals Inc., Quintiles and Organon Inc.